カテゴリ： Market Monitor Global, 世界, 医療/バイオ

メチシリン耐性黄色ブドウ球菌（MRSA）検査システムのグローバル市場展望 2023年-2029年：免疫診断学、分子診断学

■ 英語タイトル：Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23JU5269）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23JU5269
■ 発行日：2023年6月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：114
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[メチシリン耐性黄色ブドウ球菌（MRSA）検査システムのグローバル市場展望 2023年-2029年：免疫診断学、分子診断学]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のメチシリン耐性黄色ブドウ球菌（MRSA）検査システム市場規模と予測を収録しています。・世界のメチシリン耐性黄色ブドウ球菌（MRSA）検査システム市場：売上、2018年-2023年、2024年-2029年
・世界のメチシリン耐性黄色ブドウ球菌（MRSA）検査システム市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のメチシリン耐性黄色ブドウ球菌（MRSA）検査システム市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「免疫診断学」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

メチシリン耐性黄色ブドウ球菌（MRSA）検査システムのグローバル主要企業は、BD Medical、 F.Hoffmann-La Roche、 Hain Lifescience、 Biomerieux、 3M、 Bio-Rad Laboratories、 Abacus Diagnostica、 Abbott、 Puritan Medical、 Diatherix、 Arlington Scientific、 AdvanDX、 GENSPEED Biotech、 Cepheid、 Luminex Corporation、 R-Biopharm AGなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、メチシリン耐性黄色ブドウ球菌（MRSA）検査システムのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のメチシリン耐性黄色ブドウ球菌（MRSA）検査システム市場：タイプ別、2018年-2023年、2024年-2029年
世界のメチシリン耐性黄色ブドウ球菌（MRSA）検査システム市場：タイプ別市場シェア、2022年
・免疫診断学、分子診断学

世界のメチシリン耐性黄色ブドウ球菌（MRSA）検査システム市場：用途別、2018年-2023年、2024年-2029年
世界のメチシリン耐性黄色ブドウ球菌（MRSA）検査システム市場：用途別市場シェア、2022年
・病院、診断研究所、学術・研究機関

世界のメチシリン耐性黄色ブドウ球菌（MRSA）検査システム市場：地域・国別、2018年-2023年、2024年-2029年
世界のメチシリン耐性黄色ブドウ球菌（MRSA）検査システム市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるメチシリン耐性黄色ブドウ球菌（MRSA）検査システムのグローバル売上、2018年-2023年
・主要企業におけるメチシリン耐性黄色ブドウ球菌（MRSA）検査システムのグローバル売上シェア、2022年
・主要企業におけるメチシリン耐性黄色ブドウ球菌（MRSA）検査システムのグローバル販売量、2018年-2023年
・主要企業におけるメチシリン耐性黄色ブドウ球菌（MRSA）検査システムのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
BD Medical、 F.Hoffmann-La Roche、 Hain Lifescience、 Biomerieux、 3M、 Bio-Rad Laboratories、 Abacus Diagnostica、 Abbott、 Puritan Medical、 Diatherix、 Arlington Scientific、 AdvanDX、 GENSPEED Biotech、 Cepheid、 Luminex Corporation、 R-Biopharm AG

*************************************************************

・調査・分析レポートの概要
メチシリン耐性黄色ブドウ球菌（MRSA）検査システム市場の定義
市場セグメント
世界のメチシリン耐性黄色ブドウ球菌（MRSA）検査システム市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のメチシリン耐性黄色ブドウ球菌（MRSA）検査システム市場規模
世界のメチシリン耐性黄色ブドウ球菌（MRSA）検査システム市場規模：2022年 VS 2029年
世界のメチシリン耐性黄色ブドウ球菌（MRSA）検査システム市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのメチシリン耐性黄色ブドウ球菌（MRSA）検査システムの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のメチシリン耐性黄色ブドウ球菌（MRSA）検査システム製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：免疫診断学、分子診断学
メチシリン耐性黄色ブドウ球菌（MRSA）検査システムのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診断研究所、学術・研究機関
メチシリン耐性黄色ブドウ球菌（MRSA）検査システムの用途別グローバル売上・予測

・地域別市場分析
地域別メチシリン耐性黄色ブドウ球菌（MRSA）検査システム市場規模 2022年と2029年
地域別メチシリン耐性黄色ブドウ球菌（MRSA）検査システム売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
BD Medical、 F.Hoffmann-La Roche、 Hain Lifescience、 Biomerieux、 3M、 Bio-Rad Laboratories、 Abacus Diagnostica、 Abbott、 Puritan Medical、 Diatherix、 Arlington Scientific、 AdvanDX、 GENSPEED Biotech、 Cepheid、 Luminex Corporation、 R-Biopharm AG
...

Methicillin-resistant Staphylococcus aureus (MRSA) testing is utilized to detect MRSAs and no other microbes. It is prominently employed in hospitals, especially in intensive care units to inhibit MRSA from spreading to other patients. On larger levels such as community and society, the MRSA test can be employed to detect the source of an outbreak. For a national level addition, testing and research may help scientists determine the cause.
This report aims to provide a comprehensive presentation of the global market for Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems. This report contains market size and forecasts of Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems in global, including the following market information:
Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems companies in 2022 (%)
The global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Immunodiagnostics Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems include BD Medical, F.Hoffmann-La Roche, Hain Lifescience, Biomerieux, 3M, Bio-Rad Laboratories, Abacus Diagnostica, Abbott and Puritan Medical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Segment Percentages, by Type, 2022 (%)
Immunodiagnostics
Molecular Diagnostics
Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Segment Percentages, by Application, 2022 (%)
Hospitals
Diagnostic Laboratories
Academic and Research Institutes
Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems revenues share in global market, 2022 (%)
Key companies Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD Medical
F.Hoffmann-La Roche
Hain Lifescience
Biomerieux
3M
Bio-Rad Laboratories
Abacus Diagnostica
Abbott
Puritan Medical
Diatherix
Arlington Scientific
AdvanDX
GENSPEED Biotech
Cepheid
Luminex Corporation
R-Biopharm AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems, market overview.
Chapter 2: Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems market size in revenue and volume.
Chapter 3: Detailed analysis of Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Overall Market Size
2.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size: 2022 VS 2029
2.2 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales: 2018-2029
3 Company Landscape
3.1 Top Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Players in Global Market
3.2 Top Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Companies Ranked by Revenue
3.3 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue by Companies
3.4 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales by Companies
3.5 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Product Type
3.8 Tier 1, Tier 2 and Tier 3 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Players in Global Market
3.8.1 List of Global Tier 1 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Companies
3.8.2 List of Global Tier 2 and Tier 3 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size Markets, 2022 & 2029
4.1.2 Immunodiagnostics
4.1.3 Molecular Diagnostics
4.2 By Type – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue & Forecasts
4.2.1 By Type – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue, 2018-2023
4.2.2 By Type – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue, 2024-2029
4.2.3 By Type – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue Market Share, 2018-2029
4.3 By Type – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales & Forecasts
4.3.1 By Type – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales, 2018-2023
4.3.2 By Type – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales, 2024-2029
4.3.3 By Type – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales Market Share, 2018-2029
4.4 By Type – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Diagnostic Laboratories
5.1.4 Academic and Research Institutes
5.2 By Application – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue & Forecasts
5.2.1 By Application – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue, 2018-2023
5.2.2 By Application – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue, 2024-2029
5.2.3 By Application – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue Market Share, 2018-2029
5.3 By Application – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales & Forecasts
5.3.1 By Application – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales, 2018-2023
5.3.2 By Application – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales, 2024-2029
5.3.3 By Application – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales Market Share, 2018-2029
5.4 By Application – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2022 & 2029
6.2 By Region – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue & Forecasts
6.2.1 By Region – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue, 2018-2023
6.2.2 By Region – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue, 2024-2029
6.2.3 By Region – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue Market Share, 2018-2029
6.3 By Region – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales & Forecasts
6.3.1 By Region – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales, 2018-2023
6.3.2 By Region – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales, 2024-2029
6.3.3 By Region – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue, 2018-2029
6.4.2 By Country – North America Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales, 2018-2029
6.4.3 US Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.4.4 Canada Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.4.5 Mexico Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue, 2018-2029
6.5.2 By Country – Europe Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales, 2018-2029
6.5.3 Germany Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.5.4 France Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.5.5 U.K. Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.5.6 Italy Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.5.7 Russia Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.5.8 Nordic Countries Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.5.9 Benelux Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue, 2018-2029
6.6.2 By Region – Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales, 2018-2029
6.6.3 China Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.6.4 Japan Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.6.5 South Korea Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.6.6 Southeast Asia Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.6.7 India Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue, 2018-2029
6.7.2 By Country – South America Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales, 2018-2029
6.7.3 Brazil Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.7.4 Argentina Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales, 2018-2029
6.8.3 Turkey Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.8.4 Israel Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.8.5 Saudi Arabia Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
6.8.6 UAE Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 BD Medical
7.1.1 BD Medical Company Summary
7.1.2 BD Medical Business Overview
7.1.3 BD Medical Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Major Product Offerings
7.1.4 BD Medical Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales and Revenue in Global (2018-2023)
7.1.5 BD Medical Key News & Latest Developments
7.2 F.Hoffmann-La Roche
7.2.1 F.Hoffmann-La Roche Company Summary
7.2.2 F.Hoffmann-La Roche Business Overview
7.2.3 F.Hoffmann-La Roche Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Major Product Offerings
7.2.4 F.Hoffmann-La Roche Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales and Revenue in Global (2018-2023)
7.2.5 F.Hoffmann-La Roche Key News & Latest Developments
7.3 Hain Lifescience
7.3.1 Hain Lifescience Company Summary
7.3.2 Hain Lifescience Business Overview
7.3.3 Hain Lifescience Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Major Product Offerings
7.3.4 Hain Lifescience Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales and Revenue in Global (2018-2023)
7.3.5 Hain Lifescience Key News & Latest Developments
7.4 Biomerieux
7.4.1 Biomerieux Company Summary
7.4.2 Biomerieux Business Overview
7.4.3 Biomerieux Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Major Product Offerings
7.4.4 Biomerieux Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales and Revenue in Global (2018-2023)
7.4.5 Biomerieux Key News & Latest Developments
7.5 3M
7.5.1 3M Company Summary
7.5.2 3M Business Overview
7.5.3 3M Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Major Product Offerings
7.5.4 3M Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales and Revenue in Global (2018-2023)
7.5.5 3M Key News & Latest Developments
7.6 Bio-Rad Laboratories
7.6.1 Bio-Rad Laboratories Company Summary
7.6.2 Bio-Rad Laboratories Business Overview
7.6.3 Bio-Rad Laboratories Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Major Product Offerings
7.6.4 Bio-Rad Laboratories Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales and Revenue in Global (2018-2023)
7.6.5 Bio-Rad Laboratories Key News & Latest Developments
7.7 Abacus Diagnostica
7.7.1 Abacus Diagnostica Company Summary
7.7.2 Abacus Diagnostica Business Overview
7.7.3 Abacus Diagnostica Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Major Product Offerings
7.7.4 Abacus Diagnostica Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales and Revenue in Global (2018-2023)
7.7.5 Abacus Diagnostica Key News & Latest Developments
7.8 Abbott
7.8.1 Abbott Company Summary
7.8.2 Abbott Business Overview
7.8.3 Abbott Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Major Product Offerings
7.8.4 Abbott Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales and Revenue in Global (2018-2023)
7.8.5 Abbott Key News & Latest Developments
7.9 Puritan Medical
7.9.1 Puritan Medical Company Summary
7.9.2 Puritan Medical Business Overview
7.9.3 Puritan Medical Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Major Product Offerings
7.9.4 Puritan Medical Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales and Revenue in Global (2018-2023)
7.9.5 Puritan Medical Key News & Latest Developments
7.10 Diatherix
7.10.1 Diatherix Company Summary
7.10.2 Diatherix Business Overview
7.10.3 Diatherix Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Major Product Offerings
7.10.4 Diatherix Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales and Revenue in Global (2018-2023)
7.10.5 Diatherix Key News & Latest Developments
7.11 Arlington Scientific
7.11.1 Arlington Scientific Company Summary
7.11.2 Arlington Scientific Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Business Overview
7.11.3 Arlington Scientific Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Major Product Offerings
7.11.4 Arlington Scientific Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales and Revenue in Global (2018-2023)
7.11.5 Arlington Scientific Key News & Latest Developments
7.12 AdvanDX
7.12.1 AdvanDX Company Summary
7.12.2 AdvanDX Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Business Overview
7.12.3 AdvanDX Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Major Product Offerings
7.12.4 AdvanDX Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales and Revenue in Global (2018-2023)
7.12.5 AdvanDX Key News & Latest Developments
7.13 GENSPEED Biotech
7.13.1 GENSPEED Biotech Company Summary
7.13.2 GENSPEED Biotech Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Business Overview
7.13.3 GENSPEED Biotech Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Major Product Offerings
7.13.4 GENSPEED Biotech Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales and Revenue in Global (2018-2023)
7.13.5 GENSPEED Biotech Key News & Latest Developments
7.14 Cepheid
7.14.1 Cepheid Company Summary
7.14.2 Cepheid Business Overview
7.14.3 Cepheid Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Major Product Offerings
7.14.4 Cepheid Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales and Revenue in Global (2018-2023)
7.14.5 Cepheid Key News & Latest Developments
7.15 Luminex Corporation
7.15.1 Luminex Corporation Company Summary
7.15.2 Luminex Corporation Business Overview
7.15.3 Luminex Corporation Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Major Product Offerings
7.15.4 Luminex Corporation Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales and Revenue in Global (2018-2023)
7.15.5 Luminex Corporation Key News & Latest Developments
7.16 R-Biopharm AG
7.16.1 R-Biopharm AG Company Summary
7.16.2 R-Biopharm AG Business Overview
7.16.3 R-Biopharm AG Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Major Product Offerings
7.16.4 R-Biopharm AG Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Sales and Revenue in Global (2018-2023)
7.16.5 R-Biopharm AG Key News & Latest Developments
8 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Production Capacity, Analysis
8.1 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Production Capacity, 2018-2029
8.2 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Production Capacity of Key Manufacturers in Global Market
8.3 Global Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Supply Chain Analysis
10.1 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Industry Value Chain
10.2 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Upstream Market
10.3 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の院内感染症検査市場予測2024年-2032年：疾患別（UTI（尿路感染症）、SSI（手術部位感染症）、肺炎、血流感染症、MRSA（メチシリン耐性黄色ブドウ球菌）、その他）、地域別
  • MRSA治療薬のグローバル市場：病院取得（HA-MRSA）、市中取得（CA-MRSA）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23JU5269 )"メチシリン耐性黄色ブドウ球菌（MRSA）検査システムのグローバル市場展望 2023年-2029年：免疫診断学、分子診断学" (英文：Methicillin-resistant Staphylococcus Aureus (MRSA) Testing Systems Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。